Annual balance sheet for GlucoTrack, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 6.06 | 2.31 | 4.49 | 5.62 | 7.38 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 0 | — | — | — | — |
| Total Inventory | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 6.11 | 2.38 | 4.87 | 5.77 | 7.67 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 0.109 | 0.04 | 0.027 | 0.154 | 0.171 |
| Other Long Term Assets | |||||
| Total Assets | 6.26 | 2.44 | 4.91 | 5.93 | 7.84 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 0.883 | 1.01 | 1.51 | 1.27 | 4.77 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 1.11 | 1.21 | 1.71 | 18.9 | 5.01 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 5.16 | 1.23 | 3.2 | -13 | 2.83 |
| Total Liabilities & Shareholders' Equity | 6.26 | 2.44 | 4.91 | 5.93 | 7.84 |
| Total Common Shares Outstanding |